About The Arthritis Program Research Group
Clinical Trials at The Arthritis Program Research Group
During the past decade, The Arthritis Program Research Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Arthritis Program Research Group" #1 sponsor was "Amgen" with 1 trials, followed by "Bayer" with 1 trials
sponsored, "Galderma R&D" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Pope Research Corporation"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Arthritis Program Research Group"
#1 collaborator was "Amgen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at The Arthritis Program Research Group
According to Clinical.Site data, the most researched conditions in "The Arthritis Program Research Group" are
"Arthritis" (1 trials), "Knee Osteoarthritis" (1 trials), "Osteoarthritis" (1 trials), "Psoriatic Arthritis" (1 trials) and "Psoriatic Arthritis (PsA)" (1 trials). Many other conditions were trialed in "The Arthritis Program Research Group" in a lesser frequency.
Clinical Trials Intervention Types at The Arthritis Program Research Group
Most popular intervention types in "The Arthritis Program Research Group" are "Drug" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Apremilast" (1 trials), "Durolane is a device, methylprednisolone in a drug" (1 trials), "Intensive Care" (1 trials) and "NSAID" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Arthritis Program Research Group
The vast majority of trials in "The Arthritis Program Research Group" are
5 trials for "All" genders.
Clinical Trials Status at The Arthritis Program Research Group
Currently, there are NaN active trials in "The Arthritis Program Research Group".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in The Arthritis Program Research Group,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The Arthritis Program Research Group, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".